Cabenuva ER 600 MG-900 MG susp 6ML
Ended Awarded
- Contract number
- SPE2DR26FQP9S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,224
Award facts
- Contract value 100% obligated
- $40,224.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $40,224.30 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension (6 mL) on November 13, 2025, with an ultimate completion date of December 5, 2025. This firm fixed price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally.
CABENUVA is a long-acting injectable antiretroviral medication used for HIV treatment and prevention, reflecting the Defense Health Agency's comprehensive pharmaceutical support requirements across the federal healthcare system. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal medical procurement standards through competitive awards across multiple therapeutic domains. This delivery order exemplifies the company's role as a critical vendor within the DLA Medical Supply Chain, fulfilling specialized pharmaceutical needs for military personnel and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQP9S?
SPE2DR26FQP9S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FQP9S worth?
The government has obligated $40,224 on SPE2DR26FQP9S.
Is contract SPE2DR26FQP9S an order under another contract?
Yes. SPE2DR26FQP9S is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP9S competed?
The extent of competition for SPE2DR26FQP9S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award